Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute of Biotechnology at the University of Virginia, U.Va. announced Thursday. Esser, who will join U.Va. May 1, earned a Ph.D. in microbiology in 1998 from […]
The post U.Va. hires AstroZeneca exec to lead Manning biotech institute appeared first on Virginia Business.
—
Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute of Biotechnology at the University of Virginia, U.Va. announced Thursday.
